Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.
This report contains market size and forecasts of Diabetic Retinopathy in Global, including the following market information:
Global Diabetic Retinopathy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetic Retinopathy market was valued at 7983.2 million in 2021 and is projected to reach US$ 11960 million by 2028, at a CAGR of 5.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Laser Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Retinopathy include Bayer, Roche, Novartis, TEVA, Alimera Sciences, Regeneron Pharmaceuticals, Boehringer Ingelheim, Kowa Group and Ohr Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Retinopathy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Retinopathy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Retinopathy Market Segment Percentages, by Type, 2021 (%)
Laser Surgery
Injection of Corticosteroids
Anti-VEGF Drugs
Vitrectomy
Global Diabetic Retinopathy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Retinopathy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Diabetic Retinopathy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetic Retinopathy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Retinopathy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetic Retinopathy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Roche
Novartis
TEVA
Alimera Sciences
Regeneron Pharmaceuticals
Boehringer Ingelheim
Kowa Group
Ohr Pharmaceutical
Quark Pharmaceuticals